Viewing Study NCT01468233


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2026-06-22 @ 9:01 PM
Study NCT ID: NCT01468233
Status: COMPLETED
Last Update Posted: 2021-07-12
First Post: 2011-11-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hidradenitis Suppurativa (HS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None placebo controlled View
None double blind View
None adalimumab View
None TNF View
None psoriasis View
None HS View
None PIONEER II View
None hidradenitis suppurativa View
None acne inversa View
None boil View
None acne View